AI Article Synopsis

  • Doxorubicin (Dox) is an effective anti-cancer drug but causes harmful effects on normal cells, particularly leading to the secretion of Nucleophosmin (NPM) in response to DNA damage.
  • NPM is released actively from human cardiac mesenchymal progenitor cells after Dox treatment and is also found increased in the plasma of treated mice, indicating its secretion occurs in vivo.
  • The study reveals that extracellular NPM affects hCmPCs by reducing cell proliferation through activation of Toll-like receptor (TLR)4, causing pro-inflammatory responses via gene expression changes.

Article Abstract

Background: Doxorubicin (Dox) is an anti-cancer anthracycline drug that causes double-stranded DNA breaks. It is highly effective against several types of tumours; however, it also has adverse effects on regenerative populations of normal cells, such as human cardiac mesenchymal progenitor cells (hCmPCs), and its clinical use is limited by cardiotoxicity. Another known effect of Dox is nucleolar disruption, which triggers the ubiquitously expressed nucleolar phosphoprotein Nucleophosmin (NPM) to be released from the nucleolus into the cell, where it participates in the orchestration of cellular stress responses. NPM has also been observed in the extracellular space in response to different stress stimuli; however, the mechanism behind this and its functional implications are as yet largely unexplored. The aim of this study was to establish whether Dox could elicit NPM secretion in the extracellular space and to elucidate the mechanism of secretion and the effect of extracellular NPM on hCmPCs.

Results: We found that following the double-strand break formation in hCmPCs caused by Dox, NPM was rapidly secreted in the extracellular space by an active mechanism, in the absence of either apoptosis or necrosis. Extracellular release of NPM was similarly seen in response to ultraviolet radiation (UV). Furthermore, we observed an increase of NPM levels in the plasma of Dox-treated mice; thus, NPM release also occurred in vivo. The treatment of hCmPCs with extracellular recombinant NPM induced a decrease of cell proliferation and a response mediated through the Toll-like receptor (TLR)4. We demonstrated that NPM binds to TLR4, and via TLR4, and nuclear factor kappa B (NFkB) activation/nuclear translocation, exerts proinflammatory functions by inducing IL-6 and COX-2 gene expression. Finally, we found that in hCmPCs, NPM secretion could be driven by an autophagy-dependent unconventional mechanism that requires TLR4, since TLR4 inhibition dramatically reduced Dox-induced secretion.

Conclusions: We hypothesise that the extracellular release of NPM could be a general response to DNA damage since it can be elicited by either a chemical agent such as Dox or a physical genotoxic stressor such as UV radiation. Following genotoxic stress, NPM acts similarly to an alarmin in hCmPCs, being rapidly secreted and promoting cell cycle arrest and a TLR4/NFκB-dependent inflammatory response.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210386PMC
http://dx.doi.org/10.1186/s12915-021-01058-5DOI Listing

Publication Analysis

Top Keywords

npm
13
extracellular space
12
human cardiac
8
cardiac mesenchymal
8
mesenchymal progenitor
8
progenitor cells
8
npm secretion
8
secretion extracellular
8
rapidly secreted
8
extracellular release
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!